Login

Financial Snapshot

Revenue
TTM
$22.43M
Gross Margin
TTM
53.8%
Net Income
TTM
-$17.19M
Current Assets
2024 Q3
$7.982M
Current Liabilities
2024 Q3
$9.929M
Current Ratio
2024 Q3
80.39%
Total Assets
2024 Q3
$25.82M
Total Liabilities
2024 Q3
$21.68M
Book Value
2024 Q3
4.139M
Cash
2024 Q3
$2.768M
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$10.02M

Stock Price

Loading...
Market Cap: $123.96 Million

About BioHarvest Sciences Inc

BioHarvest Sciences, Inc. develops bio-cell growth platform technology. The firm leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The company is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.

Industry: Pharmaceutical Preparations

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support